| Primary |
| Angina Pectoris |
38.5% |
| Cardiac Failure |
38.5% |
| Coronary Artery Disease |
7.7% |
| Myocardial Infarction |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
|
| Supraventricular Tachycardia |
50.0% |
| Vertigo |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
66.7% |
| Hypertension |
10.5% |
| Prinzmetal Angina |
5.3% |
| Prostate Cancer |
5.3% |
| Cardiovascular Disorder |
3.5% |
| Chest Pain |
3.5% |
| Myelofibrosis |
1.8% |
| Orthostatic Hypotension |
1.8% |
| Peritoneal Dialysis |
1.8% |
|
| Presyncope |
27.3% |
| Loss Of Consciousness |
9.1% |
| Malaise |
9.1% |
| Mental Disorder |
9.1% |
| Muscular Weakness |
9.1% |
| Paraesthesia |
9.1% |
| Syncope |
9.1% |
| Toxicity To Various Agents |
9.1% |
| Ventricular Fibrillation |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.9% |
| Hypertension |
5.7% |
| Chronic Obstructive Pulmonary Disease |
5.0% |
| Cardiac Disorder |
4.5% |
| Pain |
4.5% |
| Drug Use For Unknown Indication |
3.7% |
| Chest Pain |
3.3% |
| Diabetes Mellitus |
3.1% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Angina Pectoris |
2.6% |
| Atrial Fibrillation |
2.1% |
| Depression |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Acute Myocardial Infarction |
1.9% |
| Anxiety |
1.9% |
| Myocardial Infarction |
1.9% |
| Prophylaxis |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Premedication |
1.4% |
|
| Nausea |
11.5% |
| Myocardial Infarction |
10.3% |
| Pulmonary Embolism |
10.3% |
| Vomiting |
7.7% |
| Pain |
6.4% |
| Pneumonia |
6.4% |
| Urinary Tract Infection |
5.1% |
| Death |
3.8% |
| Perirectal Abscess |
3.8% |
| Somnolence |
3.8% |
| Thrombocytopenia |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
| Anaemia |
2.6% |
| Dyspnoea |
2.6% |
| Endocarditis |
2.6% |
| Eye Disorder |
2.6% |
| Hypertensive Crisis |
2.6% |
| Malaise |
2.6% |
|
